ARGNF:OTCMKTS
argenx SE
US$ ७९०.१५
०.००%
(०.००) 1D
अक्टोबर १३, १०:३९:५८ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Mkt. cap
५१.५१ अरब
Avg. vol.
१४.००
Volume
०.००
52-wk high
US$ १,०२०.००
52-wk low
US$ ७०८.७२
Beta
०.४६
Shares outstanding
६.२९ करोड
No. of employees
२ हजार
Mkt. cap
५१.५१ अरब
Avg. vol.
१४.००
Volume
०.००
52-wk high
US$ १,०२०.००
52-wk low
US$ ७०८.७२
Beta
०.४६
Shares outstanding
६.२९ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
ad-hoc-news.de
·
६ घण्टा पहिले
argenx reports trial results: what it means for argenx stock
TipRanks
·
१७ घण्टा पहिले
Argenx Stock Stumbles As Trial Failure Haunts Rally
ad-hoc-news.de
·
१ दिन पहिले
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
१ दिन पहिले
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE